Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-25 @ 3:47 AM
NCT ID:
NCT03193502
Brief Summary:
-Rivaroxaban is factor Xa inhibitor
Detailed Description:
PVT is a common complication of liver cirrhosis
Study:
NCT03193502
Study Brief:
Protocol Section:
NCT03193502